InvestorsHub Logo
Followers 48
Posts 2681
Boards Moderated 0
Alias Born 12/19/2015

Re: Fireman02360 post# 476250

Thursday, 05/19/2022 5:23:15 PM

Thursday, May 19, 2022 5:23:15 PM

Post# of 708189
You have not been around very long, Fireman. At least with respect to this company. I, like many, have been here for 10 years or more. If I asked you about the UK “real estate deal” you would probably have no idea what I was talking about. If I mentioned the attempted hostile takeover that was attempted about 8 yrs ago, again you would likely be clueless. I assume you have seen the ASCO presentation when patients and their family members basically said DCVAX saved their lives but I could be wrong. Management has a plan and I, and others I know, intend to give them a little more time. Bottom line is we now know a phase 3 trial in GBM just met OS endpoints with impressive statistical significance in BOTH newly diagnosed and recurrent GBM and on top of that the treatment more than doubled long term survival in both as well with essentially NO SIDE EFFECTS. Put this data in front of any GBM patient and ask what he/she wants to do. Oh and by the way the technology is applicable to ALL solid tumor cancers. You may or may not know much about DCVAX Direct since you are new here but it’s applicable to inoperable tumors. Think about discussing this technology with a patient that has just received the news that he/she has an inoperable malignant tumor.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News